“The Impending Epidemic of Cardiovascular Diseases in Patients With Cancer in Japan.” Yuji Okura, Kazuyuki Ozaki, Hiroshi Tanaka, Tatsuya Takenouchi, Nobuaki Sato, Tohru Minamino https://t.co/BuF6nCAZlr

We tested Prasugrel (3.75mg) monotherapy after optimal PCI with SYNERGY stent for CCS patients, showing no incidence of ischemic and major bleeding events during 3 months follow-up. #23JCS By Takashi Muramatsu @taka_muramatsu https://t.co/6Z3DHWGzVN #circ_j https://t.co/KHzLX4Tpyc